MM
Mayank Mamtani B. Riley Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
21%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
95.2%
Neutral
4.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Communication Services
Healthcare
Communication Services
Entertainment
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Downgraded
| $14 |
14%
downside
| 2 | +1.9% |
0
%
| 4 Mar ‘26 3 months ago |
|
|
|
Buy
Reiterated
| $150 |
145%
upside
| 3 | +59% |
0
%
| 23 Feb ‘26 3 months ago |
|
|
|
Buy
Maintained
| $108 |
51%
upside
| 3 | +7.6% |
0
%
| 21 Jan ‘26 4 months ago |
|
|
|
Buy
Initiated
| $9 |
130%
upside
| 1 | +116% |
0
%
| 10 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $42 |
6%
upside
| 1 | -3.8% |
0
%
| 1 Dec ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $40 |
72%
upside
| 2 | +20% |
0
%
| 21 Nov ‘25 6 months ago |
|
|
|
Buy
Initiated
| $12 |
133%
upside
| 1 | -6.3% |
0
%
| 19 Nov ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $16 |
74%
upside
| 1 | +35% |
0
%
| 10 Nov ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $74 |
90%
upside
| 3 | +17% |
0
%
| 1 Oct ‘25 8 months ago |
|
|
|
Buy
Maintained
| $560 |
12%
upside
| 2 | +18% |
0
%
| 29 Sep ‘25 8 months ago |
|
|
|
Buy
Maintained
| $55 |
9%
upside
| 1 | -11% |
0
%
| 17 Sep ‘25 9 months ago |
|
|
|
Buy
Initiated
| $20 |
876%
upside
| 1 | -68% |
0
%
| 26 Aug ‘25 9 months ago |
|
|
|
Buy
Maintained
| $18 |
582%
upside
| 1 | +0.83% |
0
%
| 13 Aug ‘25 10 months ago |
|
|
|
Buy
Maintained
| $5 |
300%
upside
| 1 | +9% |
0
%
| 16 Jun ‘25 12 months ago |
|